Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.
Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. ; Journal Article ; Research Support, Non-U.S. Gov't ; SCOPUS: ar.j ; info:eu-repo/semantics/published
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2013 |
Schlagwörter: | Cancérologie / Médecine pathologie humaine / Adult / Aged / 80 and over / Belgium / Breast Neoplasms -- genetics -- pathology / Carcinoma -- genetics / Comparative Genomic Hybridization / Decision Making / Feasibility Studies / Female / Genomics / Hospitals / Community / Humans / Middle Aged / Neoplasm Grading -- methods / Neoplasm Invasiveness / Neoplasm Metastasis / Nucleic Acid Hybridization / Oligonucleotide Array Sequence Analysis / Prognosis / Prospective Studies / Temperature |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28944839 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/157836 |